Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMH1P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,910
Award facts
- Contract value 100% obligated
- $30,910.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,910.26 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, indicating this order supports pharmaceutical supply needs within the federal healthcare system.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement extending through December 2026 that provides comprehensive global pharmaceutical support to military and federal healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's significant IDC with DLA enables it to serve customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMH1P?
SPE2DR26FMH1P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FMH1P worth?
The government has obligated $30,910 on SPE2DR26FMH1P.
Is contract SPE2DR26FMH1P an order under another contract?
Yes. SPE2DR26FMH1P is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMH1P competed?
The extent of competition for SPE2DR26FMH1P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award